John R Hyngstrom

4PUBLICATIONS
74CO-AUTHORS
Predictive and prognostic markersAllergyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 03, 2026
Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.

George Ansstas, Karam Khaddour, Sumedha Sudhaman

|Jun 11, 2025
Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas.

Kevin J Harrington, Stephane Champiat, Joshua D Brody

|Jul 01, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.

Eric A Smith, Rachel L Belote, Nelly M Cruz

|Aug 23, 2022
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma.

Jason A Chesney, Antoni Ribas, Georgina V Long

Pageof 1

Frequent Collaborators

1 joint publications

Jason A Chesney

1 joint publications

Antoni Ribas

1 joint publications

Georgina V Long

1 joint publications

John M Kirkwood